In Case You Missed It
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Icahn may have a tough time finding interest in this behemoth.
These two large-cap drug giants should be core parts of any well-diversified portfolio.
The company discusses potential share repurchases and its acquisition strategy.
In highlights from this week's trading diary and posts, Kass discusses a difference between the equity and the fixed-income markets, and watches as the market bends, just a little.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.